Core Team

FINNCURE is led by a team with experience across nanomedicine,
drug development and delivery, medical devices, regulation,
global business and finance, and contract law.

Erik Niemelä, PhD

Founder, CTO/CSO

PhD in cell biology. Expert in nanoparticle design, translational R&D, and targeted therapeutics, with 15+ years of experience in drug delivery, medical devices, and diagnostics.

Pasi Sorvisto, MSc

Co-Founder, CBO

Business and finance executive with 20+ years of experience building and scaling companies in biotech, diagnostics, and health IT. Founder of SPARK Finland.

Jani Virtanen, D.Sc. (Tech.)

Co-Founder, COO

Serial entrepreneur with 20+ years of experience in medical device companies, specializing in operations, quality, R&D, and manufacturing scale-up.

Pei Zhang, PhD

Head of Particle Development

Expert in particle design, peptide engineering, and lipid-based nanotechnology. PhD from the University of Helsinki with experience in drug delivery and protein-based microparticles.

Susanna Seppä, MSc

Business Development

Experienced in neuroscience and clinical research, with focus on partnerships, early- stage development, and commercialization strategy.

Rainer Hilli, LLM

Senior Advisor, Intellectual Property

Partner at Roschier Attorneys. Expert in intellectual property with 30+ years of international experience in patent strategy, patent litigation, and licensing in the field of pharmaceutical and medical device industries.

Jari Pajasmaa, MSc

Senior Business Development

Pharma industry executive with +30 years of experience in multiple therapeutic areas. Special interest in severe rare disease and infectious disease drug development and commercialization.

Advisors and Network

FINNCURE works closely with a network of advisors and partners across scientific research, intellectual property, regulatory affairs, preclinical studies, clinical development, and commercialization.

Find out more